Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
13
Number of overlapping holdings
22.0%
% of HELX's 66 holdings also in FBT
43.3%
% of FBT's 32 holdings also in HELX
Overlap by Weight
Sector Drift (HELX minus FBT)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in HELX |
Weight in FBT |
Overlap | |
|---|---|---|---|---|
 |
NATERA INC | 5.7% | 4.2% | 4.2% |
|
VERTEX PHARMACEUTICALS INC | 5.2% | 2.9% | 2.9% |
|
UNITED THERAPEUTICS CORP | 2.6% | 3.4% | 2.6% |
 |
BIONTECH SE SPONSORED ADR | 2.5% | 3.2% | 2.5% |
|
REGENERON PHARMACEUTICALS | 3.9% | 2.4% | 2.4% |
Position Highlights (Non-Overlapping Exposures)
HELX Overweight Relative to FBT
|
ELI LILLY & CO | 4.6% |
 |
SAMSUNG BIOLOGICS CO., LTD. | 4.2% |
|
KRYSTAL BIOTECH, INC. | 4.2% |
|
THERMO FISHER SCIENTIFIC INC | 4.1% |
|
DANAHER CORP | 4.0% |
|
MEDPACE HOLDINGS, INC. | 4.0% |
|
CADENCE DESIGN SYS INC | 2.5% |
 |
ASTRAZENECA PLC-SPONS ADR | 2.5% |
|
CORTEVA INC | 2.4% |
|
VERTEX PHARMACEUTICALS INC | 2.3% |
HELX Underweight Relative to FBT
|
EXELIXIS INC | -4.4% |
 |
ARGENX SE ADR | -4.0% |
|
CORCEPT THERAPEUTICS INC | -3.9% |
|
ACADIA PHARMACEUTICALS INC | -3.9% |
|
INTRA-CELLULAR THERAPIES INC | -3.8% |
|
GILEAD SCIENCES INC | -3.8% |
|
CATALYST PHARMACEUTICAL PART | -3.6% |
|
INCYTE CORP | -3.6% |
|
WATERS CORP | -3.6% |
 |
ALKERMES PLC | -3.5% |